Board Briefing >> CQC Assessment >> Board Accountability >> Standards & Cross-System Learning >> PSIRF Transition Services
This requirement is key. Helpfully some broader considerations are explored through a set of questions that the PSIRF suggests leaders should ask themselves.
“Questions leaders should ask to support review:
Sources: a, NHS staff survey; b, National Reporting and Learning Explorer Tool; c, relevant board meetings; d, organisational strategies for improvement; e, reports on quality improvement activity; f, feedback from those affected by patient safety incidents and staff
Page 38 PSIRF Introduction
These questions are important, and we could add more. Some organisations will be able to positively answer the questions above. We suggest you also consider the following – how to create an evidence base?
The PSIRF states:
“Providers should agree their Patient Safety Incident Response Plans with their lead commissioners and publish a summary document on their websites, followed by annual reports of PSII activity and improvement plans. Publication should align with related information about Learning from Deaths where applicable.
Leaders must be able to demonstrate how the organisation:
The last point is critical, requiring evidence that your Patient Safety Incident Response Framework is fit for purpose, and that all systems, processes, policies are delivering improved safer care. This may become a new measure by which providers could be held to account.
In other words, ‘we have given you the Framework now prove you have made it work’ – not unreasonable, but complex and time-consuming. From our experience we know clinicians want to learn and they want the organisation to learn, however this requires genuine, meaningful and focussed engagement – this will then deliver long-lasting improvement.
The Framework’s masterstroke is baked-in accountability at the most senior of levels. The clear stipulation of ‘R&R’ (which obviously does not mean rest and relaxation) but instead roles & responsibilities, this approach will go a long way in elevating the importance of learning from incident. The burden this will place on boards should not be underestimated, though ultimately should be welcomed by all.
“Appendix 2: Roles and responsibilities, page 62 PSIRF Introduction
Roles, responsibilities and accountability need to be clear to ensure an appropriate response to patient safety incidents.
Trust boards (including board quality sub committees) will be held to account for the following:
Chief Executive will be held to account for the following:
Governors (where applicable) will be held to account as follows:
Hold the board and non-executive directors to account for:
We found it reassuring to see that Governors have been included, however the role itself may require remodelling in some organisations, and greater thought as to the training of Governors may also need to be considered.
We now consider the role of the individual tasked by the Board to ensure the PSIRF works as intended. As can be seen from the undernoted, this is a considerable role, and therefore Boards will need to carefully consider whom fulfils it.
“Executive lead for supporting and overseeing implementation of the PSIRF, this may be the person with overarching responsibility for quality or more specifically patient safety. They must be a member of the board or executive team and equipped (through training and professional development) with up-to-date safety skills, knowledge and experience, including conduct of patient safety review and investigation; knowledge of and appropriate responses to human factors; application of ‘being open’ and Duty of Candour principles; systems thinking/systems-based design; and quality improvement practices (including leadership for improvement).
Ultimately at the heart of the PSIRF, is the way an incident review is undertaken (please note we do not call them investigations – we prefer learning review).
The sign off process for a completed incident review is becoming a more rigid, which we fully support and addresses the issue of little process governance in some organisations.
“Patient safety incident investigation
This framework places the responsibility for the sign-off of locally led (that is, provider-led) PSIIs with the board(s)/leaders of the organisation(s) involved. This means that someone who meets the training requirements for PSII and oversight should be responsible for reviewing a PSII report in line with the national PSII standards and signing it off as finalised, all overseen by an executive who meets the training requirements for PSII and investigation oversight.“
SOURCE: Page 53 PSIRF Introduction
The following graphic neatly sums up the vision of how the systems will interconnect from a governance perspective. How this will work in practical terms remains to be seen but we support the theory and logic.
Source:
Patient Safety Incident Response Framework 2020: An introductory framework for implementation by nationally appointed early adopters, NHS England & NHS Improvement, March 2020
Lorraine works with healthcare providers to identify and learn from risks to improve patient safety. Her work focusses on shaping systems and processes to provide early warnings for proactive risk management. Client programmes are anchored in the principles of engagement, transparency and leveraging data. Meaningful frontline engagement, using elements of Design Thinking, has enabled clients to better understand functional and cultural issues that inhibit learning.
Lorraine has applied this in Acute, Community and Mental Health settings. She has collaborated with the Stanford Risk Authority (of Stanford University Hospitals) for more than seven years focusing on innovative risk management processes.
Lorraine has worked in healthcare for almost 20 years and is a managing director of Price Forbes Healthcare. Lorraine holds a BA in Political Science and Economics.
Mark’s specialist clinical risk management knowledge centres around medical facilities including: Acute Hospitals, Mental Health and Community health including in Primary Care.
Mark has advised various Government bodies such as, Dept of Health and Ministry of Justice, by sitting on specially convened panels and industry sector groups to advise on clinical risk and indemnity, within the UK healthcare environment and similar healthcare economies across Europe.
Mark has worked closely with the healthcare regulators assisting these bodies in reviewing and assessing clinical risk, within all aspects of Healthcare, including public, private, not for profit and charitable sectors.
Mark is a managing director of Price Forbes Healthcare and read Law at Cambridge University, where he gained an MA.